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use#LAAPesticide Spraying and 
Health Effects
I noticed with interest the article “Pesticide
Spraying for West Nile Virus Control and
Emergency Department Asthma Visits in
New York City, 2000” by Karpati et al.
(2004). I am a physician who treats hun-
dreds of patients with chronic illness from
chemical overexposure. Many of these
patients have toxic encephalopathy, reactive
airway disease, and other chemically induced
organ system damage. When my patients
become ill from pesticide spraying, they usu-
ally do not head for an emergency room,
where they typically experience long waits in
an environment containing germicidal
residue, scented products, carbonless copy
paper, hospital linens with heavy fabric soft-
ener, and other exposures. In addition, they
have learned from experience that emergency
department personnel often do not under-
stand their condition and do not know how
to treat it. Thus your survey, while with
admirable intent, greatly underestimates the
problem of respiratory exacerbation from
West Nile virus pesticide use. Many of my
patients have experienced severe neurologic
and respiratory exacerbations as well as other
organ system damage, such as significant
increase in liver enzymes, from exposure to
residue from pesticide spraying for West Nile
virus. In addition, it is my understanding
that these pesticides are not effective for con-
trolling adult mosquitoes and that the
Centers for Disease Control and Prevention
and other authorities recommend larvae con-
trol. The extent of exacerbation of illness
caused by pesticide use for West Nile virus
control is likely greater than the number of
cases of West Nile virus.
Persons who are at increased risk for
symptom exacerbation from pesticide spray-
ing such as that used for West Nile virus
control include individuals with migraines,
chronic sinus problems, asthma, reactive
airway disease, autoimmune diseases (many
of which are exacerbated by pesticide expo-
sure), and conventional allergies (Kipen et
al. 1994). There is increased respiratory
inflammation with conventional allergies,
and pesticides more readily enter the body
because the barrier function of the respira-
tory tract is further compromised. In addi-
tion, Karpati et al. (2004) failed to take
note of the U.S. Environmental Protection
Agency (EPA) final report “Principles of
Neurotoxicity Risk Assessment” (U.S. EPA
1994). This document confirmed the lack
of a blood–brain barrier between the nose
and the brain, so that pesticides readily
enter the body through the nose and pass
directly to the brain. This report further
confirmed the unusual vulnerability of the
brain to neurotoxicants: pesticides are
lipophilic and therefore seek out lipid tissue
such as the brain, and because the brain has
unusually long neurons, repair of damage in
the neurons occurs much less readily than
in other body cells.
Other groups at increased risk of pesti-
cides are those with chronic obstructive lung
disease, toxic encephalopathy, and neural
degenerative diseases. Pyrethroid pesticides
are significant neurotoxins (Eells et al. 1992;
McDaniel and Moser 1993; Tippe 1993;
Vijverberg and van den Bercken 1990), and
because they are increasingly replacing
organophosphates, they now account for a
large proportion of the pesticide-induced
chronic illness among my patients.
Emergency room visits are merely the tip of
the iceberg, and patients with many of these
disorders usually avoid the emergency room.
Thus, the use of emergency rooms is not a
sensitive indicator of body damage from
pesticides.
In my experience, the use of nebulized
glutathione, the major antioxidant and
major detoxifying agent of the body
(Klaassen et al. 1986), when combined with
lipoic acid, helps to improve an individual’s
ability to detoxify (Packer et al. 1995);
lipoic acid reactivates glutathione in lipid-
and water-based tissues. Also, nebulized
glutathione combined with adequate
buffered vitamin C reactivates glutathione
in water-based tissues.
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Pesticides and Health Effects:
Karpati et al. Respond
In her letter, Ziem raises the issue of exacer-
bations of respiratory illness and other
health effects of pesticide exposure that we
did not measure in our study (Karpati et al.
2004). Our analysis was designed to evaluate
only whether a population-level effect on
emergency department visits, specifically on
asthma and other respiratory illnesses, was
evident following pyrethroid pesticide spray-
ing. Similar study designs, despite their limi-
tations, have proven to be sensitive methods
of identifying population-level health
impacts from exposure to criteria air pollu-
tants from exposure to unusual events, such
as smoke from forest fires. Moreover, our
analysis did identify adverse population-level
health effects of elevated ozone and particu-
lates. As we noted in our discussion, the
results of the analysis for pesticide exposure
do not rule out the possibility that certain
individuals might have been affected by
exposure to the agent. Also, our focus was
on emergency department visits, which gen-
erally signify more serious illness, although
in urban neighborhoods even milder ill-
nesses are often treated in such settings.
However, if, in fact, certain individuals
experienced asthma exacerbations following
exposure, we believe our study demonstrates
that their number was small enough that it
did not result in a population-level increase
in emergency department visits for asthma
and chronic obstructive pulmonary disease. 
In our analysis we evaluated only respira-
tory complications of pesticide spraying to
control West Nile virus, and we did not pur-
port to measure possible neurotoxic or other
nonrespiratory effects. Also, we did not eval-
uate the efficacy of pesticide spraying for
mosquito control or its cost–benefit ratio
with regard to pesticide-related health effects.
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“Epidemiology of Health
Effects of Radiofrequency
Exposure”
In a recently published review (Kundi et al.
2004) on mobile phone use and cancer, we
concluded that 
Epidemiological studies that approached reason-
able latencies [time period between first exposure
and diagnosis] consistently observed elevated risk
for the development of neoplastic diseases.
This assessment is distinctly different from
the main message of the review from the
International Commission for Non-Ionizing
Radiation Protection (ICNIRP; Ahlbom
et al. 2004). The authors stated that 
Results of these studies to date give no consistent
or convincing evidence of a causal relation
between RF [radiofrequency field] exposure and
any adverse health effect.
Although the use of subjective terms is some-
times unavoidable in the context of risk
assessment (e.g., to evaluate sufficiency of evi-
dence), the decision whether or not it evi-
dence is “convincing” should be left to the
reader. Furthermore, what constitutes consis-
tent evidence or the lack of it is unclear when
the scope is as broad as the authors implied in
their reference to a “causal relation between
RF exposure and any adverse health effect.”
This review of epidemiologic evidence
addressed the issue of causation without any
consideration of the concept of causation in
epidemiology, and it failed in its essential
task to assess the possible association between
exposure to RF and health. Concerning can-
cer, Moolgavkar and Luebeck (2003) have
shown that agents that increase the growth
rate of preneoplastic cells may have a dis-
tinctly greater impact on cancer incidence
than agents that induce malignant transfor-
mation. However, this holds only for agents
that act for prolonged periods of time.
Regarding the natural history of cancer, a
noticeable effect at the population level will
only occur many years (and possibly decades)
after first contact with the promoting agent.
Although Ahlbom et al. (2004) pointed to
the insufficient latencies in epidemiologic
studies, they did not draw the straight-
forward conclusion—to assess the relation-
ship between the latencies covered in the
studies and their outcome. 
Although there is agreement between
Ahlbom et al. (2004) and us (Kundi 2004;
Kundi et al. 2004) that epidemiologic studies
of RF/microwave exposure generally have
deficiencies concerning exposure assessment,
we must not ignore that the consequence of
exposure misclassification is predominantly a
bias of risk estimates towards the zero
hypothesis.
Another aspect that has contributed to,
in our view, the inappropriate assessment of
evidence is their view about the end points of
the investigations. Among malignancies
studied so far, the most heterogeneous group
are brain tumors that comprise benign as
well as malignant neoplasms with grossly dif-
ferent cellular origin, growth behavior, and
fate. Until now no risk factor for brain
tumors has firmly been established except
ionizing radiation for meningeoma and
menigeal sarcoma and less consistently for
other brain tumors. Regarding brain tumors
of high malignancy, little is known about
induction periods and the steps necessary to
reach the final invasive state; however, case
reports of glioma after sellar irradiation
(Simmons and Laws 1998) suggest an aver-
age induction period of about 10 years.
Therefore, because exposure started too late
for an effect during initiation and because
proliferation is too fast for an effect on
growth rate, brain tumors of highest malig-
nancy must be studied very thoroughly in
relation to latency, which was not the case
for most of the studies published so far.
Disregarding these conditions will strongly
dilute any possible effect. 
Except for insufficient latency, other
sources of possible bias were mentioned by
Ahlbom et al. (2004), but again without
consideration of the consequences on risk
indicators. Ahlbom et al. (2004) stated
that 
Several of these studies did not follow workers
after they left the job of interest (Garland et al.
1990; Grayson 1996; Szmigielski 1996), with the
potential for bias if individuals left employment
because of health problems that subsequently
turned out to be due to cancer.... 
The presence of this bias in these studies
would have reduced the power in the case of
no relation between exposure and the likeli-
hood of leaving employment due to early
signs of the target disease, or it would have
led to a bias of risk estimates in the direction
determined by the sign of the correlation
between exposure and leaving service. It is
quite likely that this correlation is positive
because early signs of brain tumors will cre-
ate problems in radio operators and also in
personnel operating and maintaining radar
equipment. Hence, the consequence of the
bias is either reduction in the precision or
inflation of risk estimates. 
The author declares he has no competing
financial interests.
Michael Kundi
Institute of Environmental Health
Center of Public Health
Medical University of Vienna
Vienna, Austria
E-mail: Michael.Kundi@meduniwien.ac.at
REFERENCES
Ahlbom A, Green A, Kheifets L, Savitz D, Swerdlow A. 2004.
Epidemiology of health effects of radiofrequency exposure.
Environ Health Perspect 112:1741–1754; doi:10.1289/
ehp.7306 [online 23 September 2004]
Garland FC, Shaw E, Gorham ED, Garland CF, White MR,
Sinsheimer PJ. 1990. Incidence of leukemia in occupations
with potential electromagnetic field exposure in United
States Navy personnel. Am J Epidemiol 132:293–303. 
Grayson JK. 1996. Radiation exposure, socioeconomic status,
and brain tumor risk in the US Air Force: a nested case-
control study. Am J Epidemiol 143:480–486.
Kundi M. 2004. Mobile phone use and cancer. Occup Environ
Med 61:560–570.
Kundi M, Hansen Mild K, Hardell L, Mattsson MO. 2004. Mobile
telephones and cancer—a review of epidemiological 
evidence. J Toxicol Envrion Health Part B 7:351–384.
Moolgavkar SH, Luebeck EG. 2003. Multistage carcinogenesis
and the incidence of human cancer. Genes Chromosomes
Cancer 38:302–306.
Simmons NE, Laws ER Jr. 1998. Glioma occurrence after sel-
lar irradiation: case report and review. Neurosurgery
42:172–178.
Szmigielski S. 1996. Cancer morbidity in subjects occupation-
ally exposed to high frequency (radiofrequency and
microwave) electromagnetic radiation. Sci Total Environ
180:9–17.
Epidemiology of
Radiofrequency Exposure:
Ahlbom et al. Respond
We thank Kundi for his comments on our
review of the epidemiologic literature on
health effects of radiofrequency exposure
(Ahlbom et al. 2004). He points out, quite
correctly, that our assessment of the litera-
ture differs from the one he and colleagues
have made in a previous review (Kundi et al.
2004). We do, however, stand by our judg-
ment that the literature we reviewed offers
little support for a causal relation between
radiofrequency exposure and disease risk.
Although quality of research varies, most of
the studies we reviewed were methodologi-
cally limited and more rigorous studies are
needed. It is obviously impossible to tell
what more sophisticated research along the
lines suggested by Kundi, and also by our-
selves, will reveal in the future. We certainly
agree that consideration of latency and vari-
ous types of bias is important and, indeed,
we did consider these at some length in our
review. 
The authors declare they have no competing
financial interests.
Anders Ahlbom
Instititute of Environmental Medicine,
Karolinska Institutet
Stockholm, Sweden
E-mail: anders.ahlbom@imm.ki.se
Environmental Health Perspectives • VOLUME 113 | NUMBER 3 | March 2005 A 151
CorrespondenceAdele Green
Queensland Institute of Medical Research
Brisbane Australia
Leeka Kheifets
School of Public Health
University of California at Los Angeles
Los Angeles, California
David Savitz
School of Public Health
University of North Carolina 
at Chapel Hill
Chapel Hill, North Carolina
Anthony Swerdlow
Institute of Cancer Research
Sutton, Surrey, United Kingdom 
REFERENCES
Ahlbom A, Green A, Kheifets L, Savitz D, Swerdlow A.
Epidemiology of health effects of radiofrequency expo-
sure. Environ Health Perspect 112:1741–1754 (2004).
Kundi M, Mild K, Hardell L, Mattsson MO. Mobile telephones
and cancer—a review of epidemiological evidence.
J Toxicol Environ Health B Crit Rev 7:351–384 (2004).
Listing Occupational
Carcinogens
The review by Siemiatycki et al. (2004) is
extremely valuable, and I am sure I will refer
to it often in the future. However, I would
like clarification on the risk classification of
some chemicals. In the text the authors state
that some chemicals, such as glass wool,
were downgraded in risk between 1987and
2002, from “possible human carcinogen”
(group 2B) classification, to unclassifiable
(group 3). This contradicts Table 5
(Siemiatycki et al. 2004), where the chemi-
cals are listed as “possible human carcino-
gens” and the authors cited the 2002
volumes of the IARC (International Agency
for Research on Cancer) Monographs; this
gives the impression that this is the most up-
to-date classification.
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Editor’s note: Siemiatycki et al. submitted
corrections to their paper, which were published
as an Erratum in the February 2005 issue of
EHP (Environ Health Perspect 113:A89). 
David Rall and the National
Toxicology Program
Concerning the 25 year history and mile-
stones of the National Toxicology Program
(NTP), McGovern (2004) failed to acknowl-
edge the huge conceptual and leadership
contributions provided by David P. Rall
(1926–1999) in the creation, development,
and continuing achievements of the NTP
(Huff 2000). Of course, Rall was the indi-
vidual most responsible for conceiving, nur-
turing, and establishing the National
Institute of Environmental Health Sciences
(NIEHS) as a world-recognized leader in
environmental health sciences. The NTP, a
natural and independent partner of the
NIEHS, was the innovative idea of Rall, who
with a few other like-minded collegial giants
in the fields of public and occupational
health, recognized the need to better coordi-
nate the disparate and often redundant toxi-
cology and health hazard identification
activities in the Department of Health and
Human Services. 
Among others, Congressman David
Obey (Wisconsin) was convinced by Rall
and key colleagues that a coordinated
national program was needed to better pro-
mote the health of the American people by
protecting them from exposures to hazardous
chemicals in the workplace, environment,
and home. Obey was instrumental in getting
Congress to endorse this need for a national
program and, after Rall’s untimely death,
encouraged Congress to name the main
structure housing NIEHS/NTP in Research
Triangle Park, North Carolina, as the David
P. Rall Building. 
Rall was supported in this innovative
and monumental NTP-forming effort by
several other distinguished pioneers in
environmental health research and public
health, including Eula Bingham, then direc-
tor of the Occupational Safety and Health
Administration; Joseph Califano, then
Secretary of the Department of Health,
Education, and Welfare (renamed the
Department of Health and Human Services);
Donald Fredrickson, then director of the
National Institutes of Health; Donald
Kennedy, then director of the Food and
Drug Administration; Cesare Maltoni, then
director of the Bologna Centre for the
Prevention and Detection of Tumours and
Oncological Research; Norton Nelson, then
director of the Institute of Environmental
Medicine (renamed the Nelson Institute of
Environmental Medicine) New York
University School of Medicine; Irving
Selikoff, then director of the Mt. Sinai
Medical Center in New York City (renamed
Mount Sinai-Irving J. Selikoff Clinical
Center for Occupational and Environmental
Medicine); Lorenzo Tomatis, then chief of
the Unit of Chemical Carcinogenesis,
International Agency for Research on Cancer
(later director of IARC); and Arthur Upton,
then director of the National Cancer Institute. 
Also, during that NTP-formative era,
Rall helped establish the 1978 Public Law
that initiated the innovative Report on
Carcinogens (Huff 1998). Now in its
eleventh edition, the RoC documents 246
chemicals, groups of chemicals, or mixtures
known or anticipated to cause cancer in
humans. Much earlier, in 1972, Rall origi-
nated the pivotally directed and most fre-
quently referenced environmental journal,
Environmental Health Perspectives. Of course,
during his illustrious career as physician,
assistant surgeon general, scientist, and
staunch public health advocate, Rall made
many more and varied contributions to
basic sciences and public health (Hinson
2000; Huff 2000, 2002; Rall 2000). 
David P. Rall, a dedicated physician and
scientist, is among a relativity small group of
exceptional public servants who have had a
deep and lasting positive impact on human
health by showing us how to understand and
improve the environment in which we live,
work, and play. To many of us who joined
with him to make a safer environment, we
clearly recognize the void he has left. 
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Potential Selection Biases
In a recent article we reported an association
[adjusted odds ratios (ORs) in the range of
2–3] between the concentrations of specific
phthalates in dust from children’s bedrooms
and doctor-diagnosed disease among children
(Bornehag et al. 2004). This study has been
A 152 VOLUME 113 | NUMBER 3 | March 2005 • Environmental Health Perspectives
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American Chemistry Council Phthalate Esters
Panel (American Chemistry Council 2004)
and the European Council for Plasticisers and
Intermediates (2004).
A major criticism of the study is based on
the assumption that families with allergic
members change their flooring from carpets to
a hard floor [e.g., polyvinyl chloride (PVC)]. If
this is true, our findings would be biased (i.e.,
families with allergic members would have rel-
atively more PVC flooring and would thus be
exposed to higher concentrations of phtha-
lates). However, very few families in Sweden
today have wall-to-wall carpets; in total, 1% of
the homes in this study reported having such
carpets, two cases and two controls. Given that
Swedish homes already have hard floors, there
is no obvious reason why allergic families
would change from one hard floor (e.g., wood)
to another hard floor (e.g., PVC). 
Still, there is some bias in the study. The
case–control study in question is based on a
cross-sectional baseline survey. The baseline
questionnaire showed that there were no indi-
cations of selection bias among cases concern-
ing self-reported flooring materials in the home
(Bornehag CG, Sundell J, Sigsgaard T, Janson
S, unpublished data). However, among con-
trols, a main difference was a significant over-
representation of wood flooring among
participating families compared with non-
participating families. Furthermore, on the
basis of inspectors’ observations, parents some-
times misclassified the type of flooring material
in their home. Quite often parents classified
PVC as linoleum or cork. 
Presuming the misclassification of
linoleum and cork is similar among participat-
ing and nonparticipating families, then the dis-
tribution of flooring materials can be
recalculated. The distribution of PVC flooring
after such a recalculation becomes 59.8%
(including cases), 61.2% (nonparticipating
cases), 51.1% (included controls), and 59.5%
(nonparticipating controls). Consequently,
cases report PVC flooring slightly more often
than controls. However, regarding hard floor-
ing, we found no bias between the groups
because 99% of the families had hard floors.
Even if PVC-flooring is associated with
phthalates in dust, it is not simply a proxy for
phthalate exposure. Several observations sup-
port such a statement. First, our study indi-
cated that there are other significant indoor
sources for phthalates because, in the absence
of PVC flooring, the dust concentrations of
plastisizers are still significant (Bornehag CG,
Sundell J, Lundgren B, Weschler CJ, Sigsgaard
T, Hagerhed-Engman L, unpublished data).
Second, the association between doctor-diag-
nosed disease and the concentration of specific
phthalates in dust was much stronger than the
association between disease and PVC flooring
(Bornehag et al. 2004). Third, the correlation
between the concentration of different phtha-
lates was rather weak (r < 0.35) (Bornehag
et al. 2004). There are still other observations
that indicate that the reported association is
not due to selection bias. Fourth, an under-
representation of about 9% of PVC flooring
among controls cannot explain reported ORs
in the range of 2–3. (However, the earlier
reported association between PVC flooring
and case status, OR 1.59, is overestimated
because there is selection bias regarding PVC
flooring among controls.) Fifth, when we
included in the analyses only buildings with
PVC in the child’s bedroom, the association
between butyl benzyl phthalate (BBzP) in dust
and rhinitis and eczema remained (Bornehag
et al. 2004). In such a restricted analysis, the
potential selection bias has been eliminated.
Finally, we found different associations for dif-
ferent phthalates: di(2-ethylhexyl phthalate
(DEHP) was associated with asthma; BBzP was
associated with rhinitis and eczema; and DnBP
was not associated with asthma or allergies. 
In summary, for the reasons stated above,
we judge that our reported association
between phthalates in dust and asthma/allergic
symptoms among children is not a conse-
quence of either selection bias or active avoid-
ance of specific flooring materials because of
allergic disease in the family.
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